Jorge Conde

Dec 10, 2024 | a16z.com | Jorge Conde |Kris Tatiossian |Olivia Webb |Carolyn R. Bertozzi

Matt Wilsey, cofounder and CEO of Grace Science, joins Jorge Conde, Bio + Health general partner, to share the profound personal story of his daughter Grace’s diagnosis with NGLY1 deficiency and how it catalyzed his journey to founding a biotech startup aimed at developing a cure for his daughter’s condition. Matt emphasizes the importance of strategic partnerships, like his collaboration with Nobel laureate Carolyn Bertozzi, and sheds light on the search for gene therapies for rare diseases.

Nov 26, 2024 | a16z.com | Carolyn R. Bertozzi |Jorge Conde |Kris Tatiossian |Olivia Webb

Nobel laureate and Stanford professor Carolyn Bertozzi joins Jorge Conde to unravel the concept of bioorthogonal chemistry. Carolyn traces her pioneering path from early studies in carbohydrate chemistry to how her lab developed the revolutionary ability to manipulate chemical reactions inside the human body. Together, they highlight the intersection of cutting-edge academic research and the challenges of translating discoveries into market-ready solutions.

Oct 31, 2024 | elplural.com | Jorge Conde

Escribo estas notas desde el cuartel de la Guardia Civil de Silla, uno de los epicentros de la tragedia, que me ha pillado de camino a un encuentro sobre Arquitectura circular y los retos de la Nueva Bauhaus Europea en la Universidad Jaume I (Jaime I de Aragón). Mientras escuchaba las terribles noticias en la emisora de la Guardia Civil, he recordado cuando estábamos jugando al fútbol en Boltaña y vimos venir una nube que era nueva para nosotros, que nunca habíamos visto antes.

Aug 31, 2024 | kyivpost.com | Jorge Conde

If surrogate propaganda – the outsourcing of state Influence Operations to third party enterprise – were a product, its label would read: “Caution: May not always operate as intended.” Case in point the PMC Wagner Group, created 10 years ago with the dual benefit objective of offering Russian terror dissemination non-accountability with Kremlin humiliation non-attribution when things go wrong.

Aug 6, 2024 | a16z.com | Jorge Conde |Ginger Liau |Kris Tatiossian |Olivia Webb

Bruce Levine, PhD, the Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania, joins Jorge Conde, general partner, and Ginger Liau, partner at a16z Bio + Health. Bruce talks about how his time working in a lab at the Children’s Hospital of Philadelphia inspired him to work on translational therapies. Together, they also discuss barriers to access for cancer therapeutics and how the fight against cancer is progressing.